PAMS
AMLX icon

Pictet Asset Management (Switzerland)’s Amylyx Pharmaceuticals AMLX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$13M Sell
601,646
-832,200
-58% -$22.5M 0.02% 567
2023
Q1 		$42.1M Buy
1,433,846
+312,081
+28% +$10.8M 0.05% 317
2022
Q4 		$41.4M Buy
+1,121,765
New +$39.8M 0.06% 308

Other funds holding AMLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s AMLX Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Amylyx Pharmaceuticals (AMLX) stake by 58% in Q2 2023, selling an estimated $22.5M and leaving 601,646 shares worth $13M. The position accounts for 0.02% of the portfolio, ranked #567.

Pictet Asset Management (Switzerland) first reported a position in AMLX in Q4 2022 and has held it in 3 quarters since. The position peaked at $42.1M in Q1 2023. 154 funds tracked by Wall St. Rank hold AMLX as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 601,646 shares of Amylyx Pharmaceuticals worth $13M as of Q2 2023.
  • Pictet Asset Management (Switzerland) sold 832,200 Amylyx Pharmaceuticals shares in Q2 2023, an estimated $22.5M.
  • Amylyx Pharmaceuticals made up 0.02% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #567 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Amylyx Pharmaceuticals in Q4 2022 and has held it in 3 quarters since.
  • Pictet Asset Management (Switzerland)'s Amylyx Pharmaceuticals position peaked at $42.1M in Q1 2023.
  • 154 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.